Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement
- PMID: 37721605
- DOI: 10.1001/jama.2023.16991
Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement
Abstract
Importance: Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10 000 deliveries in 1993 to 1021 cases per 10 000 deliveries in 2016 to 2017.
Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy.
Population: Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension.
Evidence assessment: The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit.
Recommendation: The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation).
Comment in
-
Hypertension Screening in Pregnancy: Remembering the Basics, Charting the Future.JAMA. 2023 Sep 19;330(11):1040-1041. doi: 10.1001/jama.2023.15088. JAMA. 2023. PMID: 37721621 No abstract available.
Summary for patients in
-
Screening for High Blood Pressure Disorders During Pregnancy.JAMA. 2023 Sep 19;330(11):1107. doi: 10.1001/jama.2023.17046. JAMA. 2023. PMID: 37721609
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
